Acute Monoblastic Leukemia

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Tipifarnib in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Mar 25, 2013
First Changed:
Jan 27, 2003
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
tipifarniblaboratory biomarker analysis
Tipifarnib in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 4, 2013
First Changed:
Jan 10, 2005
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
tipifarnibpharmacological studylaboratory biomarker analysis
Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies
Status:
Completed
Last Changed:
Jan 23, 2019
First Changed:
Mar 26, 2010
Disease(s):
Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
Intervention(s):
double-unit umbilical cord blood transplantationcytogenetic analysisbone marrow aspirationfluorescence in situ hybridizationbusulfancyclophosphamideanti-thymocyte globulinmethylprednisolonecyclosporinemycophenolate mofetilflow cytometryallogeneic hematopoietic stem cell transplantation

Connect. Empower. Inspire.